We cordially invite you to the 4th International Conference 4th International Conference on Virology and Infectious Diseases, which will be held in Dubai, UAE, on November 27-29, 2023. Virology 2023 introduces a new platform for sharing and debating all advances in the field of virology and infectious diseases. As we approach the year 2023, one only needs to look at the daily news to understand the ongoing burden of viral diseases.
Virology 2023 is not only a stage to exchange estimations to a large social gathering of people, but it is also an impetus to do, spread focused, and research advances in the field of Virology. Meet the world's most inspiring specialists and speakers in our medical specialty to discuss new advances in medicine and engineering to improve health and treatment, as well as additional innovations in the field of Virology & Infectious Diseases.
Virology 2023 will be an excellent opportunity to network, learn, and interact with professionals in the fields of virology, microbiology, infectious diseases, medical specialties, and biological science.
It is our philosophy to provide participants with exposure, so we ensure that the event is a mix of professionals such as Virologists and Microbiologists Researchers, making Virology 2023 a perfect platform. As a result, we cordially invite all interested parties from industry and academia to join us at our convention and help make it a success through your participation.
The theme of the conference will be ‘Virology and Infectious Diseases’. Our ultimate goal for this conference is to provide an outstanding program that covers the entire spectrum of advanced research and innovation in Virology, as well as to share our experience with various treatment procedures for Infectious Diseases.
Virology 2023 aims to bring together researchers, principal investigators, specialists, and professors from academia and the health care industry, as well as business delegates, scientists, and students from around the world, to present their research findings, new ideas, and practical development experiences at Virology and Microbiology, which will be held during November 27-29, 2023 at Dubai , UAE, UAE. We hope you will take advantage of this educational opportunity to revitalize your long-standing relationships and connect with news all over the world.
Virology 2023 has been organized in such a way that each segment has a number of sessions/tracks to choose from, providing a unique opportunity to meet with peers from both industry and academia and establish a scientific network.
Many interesting Oral presentations, Keynote presentations, Poster Presentations, Exhibitions, Workshops, and a short note by eminent personalities from around the world will be presented at the Virology 2023 conference. We hope that you will take advantage of this year's Conference to rekindle existing connections and forge new ones with your colleagues from around the world. With members from all over the world interested in learning about virology and its diseases, this is often your best chance to meet the most people in the scientific community.
At this conference, you will have the opportunity to meet experts, strengthen and update your knowledge of Virology, Microbiology, and Infectious Diseases. We can fight deadly infectious diseases together by raising awareness, and Virology 2023 is an excellent platform for this.
Top Associations and Societies of Virology:
1. Center for Emerging Viral Infections Research
2. Hunter Medical Research Institute
3. Center for Global Research and Intervention in Infectious Diseases
4. Infectious and Immunologic Diseases Research Center
5. Global virus network
6. HIV Medicine Association
7. International AIDS Society
8. Canadian Society for International Health
Who should attend?
With members from all over the world interested in learning about virology and its advancements, this is your best chance to reach the most people in the community of virologists, microbiologists, and other researchers. At this two-day event, you can give presentations, share information, meet with current and potential scientists, make a splash with new discoveries in the treatment and diagnosis of infectious diseases, and gain name recognition. This conference features world-renowned speakers, the most recent techniques, developments, and the most recent updates in the use of Microorganisms, their uniqueness, and role in the research field.
·Specialist in infectious diseases and tropical medicines
·Food and Beverages Industries
·Virology Young researchers
·Public Health Virologist
·Quality Control Clinicians
·Doctor of Philosophy
·Virology and Microbiology Faculty
·Virology and Microbiology Associations and Societies
·Manufacturing Medical Devices Companies
·Deans and Professors
·For Researchers and Faculty Members
·Symposium hosting (4- 5 member team)
For Universities, Associations & Societies:
For Students and Research Scholars:
·Poster Competition (Winner will get Best Poster Award)
·Young Researcher Forum (YRF Award to the best presenter)
For Business Delegates:
·Book Launch event
For Product Manufacturers:
·Exhibitor and Vendor Booths
·Marketing and Networking with clients
Salient Features of the Conference:
·Meet academe and trade visionaries to get impressed
·Expand your data and realize solutions to issues
·Knowledge, Benchmarking and Networking offered at one place
·Forge connections and for world networking
·Highly Organized and Structured Scientific programs
·Poster shows and foremost exhibitions
·Participation by Stalwarts from varied international societies
·Internationally notable speakers and scientist’s illustration
·Career steerage for early career researchers and students
·Interesting scientific deliberations and discussions
·Perfect platform for the world Networking
Sessions 01: Virology
Virology is the investigation of infections and infection like organic entities, which are sub infinitesimal parasitic microorganisms with hereditary material encased in a protein coat. It centers around the construction, arrangement, and development of infections, as well as their strategies for tainting and taking advantage of host cells for generation, their cooperation with have living being physiology and resistance, the illnesses they cause, disengagement and culture procedures, and their utilization in examination and treatment. Microbial science has a subfield called Virology.
·Physiology, molecular biology
·Clinical aspects of viruses
Session 02: Clinical and Medical Virology and Parasitology
Clinical parasitology customarily has incorporated the investigation of three significant gatherings of creatures: parasitic protozoa, parasitic helminthic (worms), and those arthropods that straightforwardly cause infection or go about as vectors of different microbes. A parasite is a microbe that all the while harms and gets food from its host. A few organic entities called parasites are really commensals, in that they neither advantage nor hurt their host (for instance, Endamoeba coli). Diseases of people brought about by parasites number in the billions and reach from generally harmless to deadly. Human parasitology is worried about the morphology, life cycle, and relationship of clinical parasites to their hosts and conditions. Parasitic sicknesses are probably going to stay testing to control, requiring new logical information to further develop control endeavours.
·Therapeutic Approaches and Targets for Viral Infections
·Immunology and Pathogenesis of Virus Infections
Session 03: Emerging Infectious Diseases
Contaminations that have as of late showed up in a populace or whose frequency or geographic reach is quick extending or take steps to increment sooner rather than later are known as arising irresistible infections. In a 2007 report, the World Health Organization forewarned that irresistible sicknesses are emerging at an exceptional rate. Around 40 irresistible infections have been found since the 1970s, including SARS, MERS, Ebola, Chikungunya, avian influenza, pig influenza, Zika, and, most as of late, COVID-19, which is brought about by the SARS-CoV-2 Covid. Individuals are voyaging considerably more every now and again and over significantly longer distances than previously, residing in more thickly populated places and drawing into nearer contact with wild creatures, so the potential for new irresistible infections to spread rapidly and trigger overall pestilences is a not kidding concern. Such sicknesses have little respect for public lines. The minority of creatures equipped for proficient human-to-human transmission can become significant public and worldwide worries as conceivable plague or pandemic causes. They can have an assortment of monetary, cultural, and restorative results.
·Seroprevalence and Surveillance
·Clinical Features and Outcomes
·Re-emergence of Infectious disease
·Infectious disease and Public Health
Session 04: Molecular Biology Research and Viral Therapy
Molecular biology is the most advanced study field for detecting infection by looking at the virus's molecular makeup. DNA cloning, DNA proliferation, bacterial transformation, transfection, and other procedures are all included in molecular treatment. Polymerase chain reaction (PCR), Southern blotting, and Northern blotting are three of the most essential procedures. Oncolytic viral treatment is a type of viral therapy for cancer. The treatment of pancreatic cancer with Oncolytic viral therapy is possible.
·Molecular Biology and Immunology
Session 05: Monkeypox - Special Session
Monkeypox is a rare virus-borne disease. It causes a rash and influenza-like symptoms. It belongs to the orthopoxvirus family, as does the more well-known virus that causes smallpox.
Monkeypox was discovered in 1958 after two outbreaks of a pox-like disease in research groups of monkeys. It is primarily transmitted through human contact with infected rodents, but it can also be transmitted through skin-to-skin contact with an infected person. Monkeypox virus has two known types (clades): one that originated in Central Africa and one that originated in West Africa. The less severe West African clade is responsible for the current global outbreak (2022).
Session 06: Coronavirus Disease (COVID-19) - Special Session
Coronavirus Disease (COVID-19) is a recently discovered coronavirus that causes an irresistible sickness. Covid are a kind of infection that can contaminate people and cause respiratory sickness. The different crown-like spikes on the outer layer of the infection give it the name "crown." Coronaviruses that cause disorder in people incorporate SARS, Middle East respiratory condition (MERS), and the normal virus. Most of patients tainted with the COVID-19 infection will have gentle to direct respiratory manifestations and will recuperate without requiring a particular treatment. Individuals beyond 65 years old, as well as those with hidden ailments like cardiovascular infection, diabetes, persistent respiratory sickness, and malignant growth, are at a higher gamble of creating major disease. The most number of impacted pregnant ladies is expanding, however scant data is accessible with regards to the clinical highlights Obstetrics Infections results of pregnant patients with COVID-19 in pregnancy brought about by serious intense respiratory condition Covid Moreover maternal, deadly, and neonatal results of patients who were tainted in late pregnancy showed up excellent, and these results were accomplished with concentrated, dynamic administration that may be the best practice without any more strong information.
The clinical attributes of these patients with COVID-19 during pregnancy were like those of non-pregnant grown-ups with COVID-19 clinical indications from 33 Infections with or in danger of COVID-19 were gentle and results were positive of the 3 children with suggestive COVID-19, gave beginning stage SARS-CoV-2 disease. Being totally educated on the COVID-19 infection, the illness it causes, and how it sends is the best procedure to stay away from and dial back transmission.
The family is divided into four distinct types:
Session 07: Cancer Virus
Cancer is any of a vast range of diseases characterised by the formation of abnormal cells that divide uncontrollably and have the ability to invade and destroy normal human tissue. Cancer has the power to spread throughout your body.
Cancer is the world's second largest cause of death. However, because of the advancements in cancer detection, therapy, and prevention, survival rates for many types of cancer are improving.
·Human Papillomaviruses (HPVs)
·Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV)
·Kaposi Sarcoma-Associated Herpes virus (KSHV)
·Merkel Cell Polyomavirus (MCV)
·Human Immunodeficiency Virus Type 1 (HIV-1, or HIV)
·Human T-Cell Lymph tropic Virus Type 1 (HTLV-1)
·Epstein-Barr Virus (EBV)
Session 08: HIV and STDs
Sexually transmitted diseases, often known as Sexually Transmitted Infections (STIs). STDs are illnesses that are transmitted from one person to another by sexual activity, such as anal, vaginal, or oral sex. Parasites, viruses, and bacteria are all responsible for STDs.
AIDS (Acquired Immune Deficiency Syndrome) is caused by the HIV virus. Having vaginal, anal, or oral intercourse with someone who has HIV without using a condom spreads HIV. If you exchange drug "works" (such as needles and syringes) with someone who has HIV, you can develop HIV. HIV weakens the body's immune system by attacking it. When a person's immune system becomes too weak to combat illnesses, he or she develops AIDS. There are medications that can help patients with HIV, but no cure for HIV or AIDS exists.
Multiple pathogen species infect a host at the same time, resulting in HIV and STDs . There are a variety of co-infections that are linked to STDs, including HIV, which can lead to death or aggravate the individual's health. Because these pathogen species can interact within the host, co-infection is of particular importance to human health. The net effect of co-infection on human health is assumed to be unfavourable; however interactions with other parasites might have either good or negative consequences.
Other examples of STDs:
·Human papillomavirus (HPV)
Session 09: Viral Hepatitis
An inflammatory disorder of the liver is referred to as Hepatitis. Hepatitis can have other probable origins besides viral infections, which are often what cause it.
These include autoimmune hepatitis and hepatitis brought on by drugs, alcohol, poisons, and other medications. When your body produces antibodies against the tissue in your liver, it develops an illness called autoimmune hepatitis.
Hepatitis A, B, C, D, and E are the five primary hepatitis virus subtypes. Each form of viral hepatitis is brought on by a distinct virus.
According to the World Health Organization (WHO), 354 million people worldwide today suffer from chronic Hepatitis B and C.
Session 10: Plant Viral Infection and Prevention
Plant viruses are viruses that cause harm to plants. Plant viruses, like all other viruses, are intracellular parasites that lack the necessary molecular machinery to replicate without a host. Plant viruses have the capacity to infect higher plants and cause illness. Plant viruses are most commonly rod-shaped, with protein discs forming a tube around the viral genome; isometric particles are another common shape. They hardly ever have an envelope with them. Plant viruses are parasitic viruses that infect plants and inflict enormous economic damage all over the world, particularly in countries where agriculture is a major source of income. Virus illness management is difficult due to the rapid mutation rate of viral genomes.
Many plant pathogens, mainly fungi, can be controlled by using compounds that interfere in some way with the invading pathogen's metabolism, so preventing or ameliorating disease. Unfortunately, these strategies cannot be utilized to control plant viruses on a large scale. Because viruses have few, if any, enzymes of their own, they rely on enzymes that are already present in host cells or those that are generated as a result of infection. These enzymes are responsible for nucleic acid and protein synthesis, and halting their action chemically disturbs the activity of other enzymes required for cell function. Viruses can be prevented, or at least mitigated, by doing the following:
·Control of vectors.
·Breeding for resistance and the use of cross-protection methods. Each of these approaches to control will be considered
·Elimination of the virus from infected plants.
·Elimination of sources of virus.
Session 11: Veterinary Virology
Viruses are smaller and less complex than unicellular microbes, and they only contain one form of nucleic acid—DNA or RNA, never both. Because viruses lack ribosomes, mitochondria, and other organelles, they must rely on their cellular hosts for energy and protein synthesis. They only reproduce within the infected host's cells. The necessity to control viral infections in humans and their domesticated animals prompted the development of animal virology in major part. Viruses, like other infectious agents, enter the body of an animal through one of the animal's surfaces. They then spread systemically by infecting one of the body's surfaces locally or by infecting lymphatic and blood arteries. Animal viruses must identify a unique cellular receptor in their hosts during infection. Host receptor binding is the first step in the virus's life cycle, and it could be a good target for preventing infection. Tissue culture is commonly used in laboratories to create animal viruses.
Here are a few of them:
·Foot-and-mouth disease virus
·Influenza (Avian influenza, Swine influenza)
·African swine fever virus
Session 12: Bacterial Virology/Bacteriophages
Bacteria are little, yet they reproduce quickly. In just a few hours, one bacterium can expand into thousands or even millions of new bacteria. Bacteriophages are tiny viruses that can cause bacteria to become infected (phage). Bacteriophages are so little that they only have one cell, which is made up of a single strand of DNA coated in a protein sheath. When bacteriophages infect a bacterium, they can rapidly expand, causing the bacteria to burst and produce a large number of young phage. There are trillions of bacteria and bacteriophages in the human body, all of which are necessary for a normal, healthy life. Bacteriophage research has grown in importance as a result of its widespread presence and tight links to bacteria. Researchers can deduce fundamental principles of genome organization, co-evolution, and genome modelling and modification by analysing bacteriophage genome sequences.
Common Bacteriophages are:
Session 13: Fungal Virology
Fungus viruses, often known as 'Mycoviruses,' infect a wide range of medically and commercially significant fungi, yet they rarely cause symptoms. In the majority of cases, Mycoviruses have double-stranded RNA (dsRNA) genomes and isometric particles, although about 30% have positive-sense, single-stranded RNA (+ssRNA) genomes. True Mycoviruses can infect and disseminate to other fungi that are healthy. Many double-stranded RNA elements identified in fungi do not fit this description, and in these cases, they are referred to be virus-like particles, or VLPs.
Fungus-caused diseases include:
·Coccidioidomycosis/Valley Fever (Coccidioides immitis and C. posadasii)
·Histoplasmosis (Histoplasma capsulatum)
·Blastomycosis (Blastomyces dermatitidis)
·Pneumocystis pneumonia (Pneumocystis jirovecii)
Session 14: Ebola and Marburg Viruses
Ebola virus disease (EVD), commonly known as Ebola haemorrhagic fever is an uncommon but deadly disease that infects individuals. After being transmitted to people from wild animals, the virus is spread across the human population through human-to-human transmission. Ebola is a rare but deadly virus that causes fever, body aches, diarrhoea, and internal and external bleeding in certain cases. The average case mortality rate for EVD is around 50%. Case mortality rates in past epidemics have ranged from 25 per cent to 90 per cent.
Marburg virus sickness is a highly contagious disease that causes haemorrhagic fever and has a fatality rate of 88 per cent. It is related to the Ebola virus, which is responsible for the disease. Constant exposure to mines or caves where Rousettus bat populations reside causes human infection with the Marburg virus. Once a person has been infected with the virus, it can spread from person to person by direct contact.
The Ebola and Marburg viruses both live in animal hosts. Viruses can be transmitted to humans from infected animals. The viruses can spread from person to person after the initial transmission by contact with body fluids or filthy materials such as infected needles. Both viruses are indigenous to Africa, where epidemics have occurred on an irregular basis for decades.
There is currently no approved treatment for the Ebola or Marburg viruses. People who have been diagnosed with the Ebola or Marburg viruses receive supportive care as well as therapy for consequences. For the Ebola virus, one vaccination has been authorised. Other vaccinations for these fatal diseases are being researched by scientists.
Session 15: Zoonotic Diseases
Animals can sometimes carry dangerous germs that transmit to humans and cause illness; these are known as Zoonotic diseases or Zoonoses. Zoonotic diseases are caused by pathogenic microorganisms such as viruses, bacteria, parasites, and fungus. These viruses can cause a wide range of ailments in humans and animals, from moderate to severe illness and even death. Depending on the zoonotic disease, animals may appear healthy even though they are carrying germs that can make people sick.
Zoonotic infections are quite widespread in the United States and throughout the world. According to scientists, more than six out of every ten recognised infectious diseases in humans can be transmitted by animals, and three out of every four novel or emerging infectious diseases in humans are transmitted by animals. As a result, the CDC works around the clock to safeguard people from zoonotic diseases in the United States and around the world.
The following are some of the disorders caused by these viruses:
·Hantavirus Pulmonary Syndrome
Session 16: Chronic Diseases
A chronic condition is the one that lasts a long time. According to the National Center for Health Statistics, a chronic condition is defined as one that lasts three months or longer. Chronic diseases, in general, cannot be prevented or cured by vaccines, and they do not simply go away. Tobacco use, inactivity, and poor dietary habits are all key contributors to the top chronic diseases. Chronic diseases grow more prevalent as people get older. Heart disease, cancer, and diabetes are the top causes of death and disability in the United States.
Session 17: Neurovirology
Clinical neuroscience, virology, immunology, and molecular biology are all part of Neurovirology, which is an interdisciplinary field. The field's main focus is on viruses that can infect the neurological system. Furthermore, the discipline investigates the use of viruses to trace neuroanatomical circuits, as well as gene therapy and the elimination of harmful populations of brain cells.
Viruses affecting the nervous system:
·Herpes viruses (Herpes simplex virus type 1 (HSV-1), Human cytomegalovirus (CMV), Varicella-zoster virus (VZV), Epstein-Barr virus (EBV))
·Polyomavirus (JC virus (JCV))
·Rhabdoviruses (Rabies virus)
·Paramyxoviruses (Measles virus, Mumps virus)
·Retroviruses (Human immunodeficiency virus (HIV)).
Session 18: Food and Environment Virology
The Food and Environmental Virology session will look at how pathogenic viruses are transmitted through the environment (air, soil, water, etc.) and foods. This comprises epidemiological investigations, the discovery of novel and emerging infections, analytical or characterisation methods, survival and elimination studies, and the establishment of industrial process procedural controls, such as HACCP protocols. The session will cover research on human, animal, and plant pathogenic viruses that can be transmitted through the environment or food.
·Routes of transmission
·Viruses in water treatment plants
·Foodborne and airborne viruses
·Transport of viruses through soils
·Elimination procedures for food and environmental application
·Procedural controls and Personal protective efforts.
Session 19: Vector-borne Diseases
Infections transmitted by the biting of infected arthropod species such as mosquitoes, ticks, triatomine bugs, sand-flies, and blackflies are known as Vector-borne diseases. Infectious diseases spread by vectors account for more than 17% of all infectious diseases, resulting in more than 7,00,000 fatalities each year. Parasites, bacteria, and viruses can all cause them.
The following are some examples of vector-borne diseases:
·Rocky Mountain spotted fever
·West Nile Virus
·Zika Virus Disease
Session 20: Viral Respiratory Diseases
Human respiratory viruses are the most prevalent cause of illness, with high rates of morbidity and mortality all across the world. Common respiratory agents from numerous virus families are the predominant etiological agents of acute respiratory infections (ARIs), according to community-based studies conducted over the last five decades. Viral respiratory disease can be mild or severe, but it is more common in the elderly and new-borns. Despite the fact that respiratory viruses cause a wide range of illnesses, there are currently just a few preventive or treatment options. On the other hand, recent advances in respiratory virus molecular and cell biology should pave the way for the creation of effective treatments.
·Paediatric Respiratory Diseases
·Pleural Cavity Diseases
·Pulmonary Vascular Diseases
·Respiratory Tract Infections
·Restrictive Lung Diseases
Session 21: Virus Proteomics
Viruses have long been used as model organisms for molecular processes and as tools for finding critical cellular regulatory proteins and pathways, as well as pathogenesis and disease. The development of proteomic approaches, combined with recent advances in mass spectrometry methods, has greatly aided the detection of virion components, protein interactions in infected cells, and virally induced changes in the cellular proteome, resulting in a much more detailed understanding of viral infection. Furthermore, the growing amount of high-resolution structures for viral proteins has benefited in the discovery and understanding of specific inhibitors that could be utilised in antiviral treatments, as well as providing important information on the mechanisms of action of these proteins.
·Acutely Infectious Virus
·Innate Immune Response
·Viral Protein Phosphorylation
·Viral Protein Ubiquitination
·Viral Proteome and Pattern Recognition
Session 22: Recent Advances in Virology Research
It may be argued that virus infections are now the most common microbial illnesses in humans, and that their failure to react to antibiotics sets them apart from bacterial infections. Prophylactic vaccination is the only efficient technique of controlling most virus diseases, and it has already proven beneficial against some viruses.
In virology, there has been a significant shift in recent years. Only two dozen viruses could be easily cultured in the laboratory twenty years ago. Virology was primarily regarded as an academic discipline with little relevance to medical practise. The number of viruses that infect humans and can be researched in the laboratory is currently around 150, and this number is continually growing.
Session 23: Vaccines Safety and Efficacy
For almost two centuries, vaccines have provided a safe and effective method of averting a number of infectious diseases. Despite recent concerns about the safety of some vaccines, the vaccines currently available are a million times safer than the diseases they are designed to prevent. Vaccines, on the other hand, should be used in conjunction with other public health initiatives wherever possible. Misinformation, which is widely available on the internet and in print, can cause the general public to believe that vaccines are dangerous and unneeded. One important solution is education. Some vaccines must be given intravenously, while others must be given orally or intranasally. Vaccines for the skin and the uterus are being studied. Only a few viral and bacterial diseases have vaccines accessible presently. Vaccines against a wide range of viral and bacterial illnesses, as well as fungal and protozoan diseases, are expected to be developed in the future.
Different COVID-19 Vaccines:
·Johnson & Johnson vaccine
·Sputnik Light vaccine
·Sputnik V vaccine
·Zydus Cadila vaccine
Virology, or the study of viruses, is a unique branch of biology. The necessity of virology is continuously emphasized due to the extremely high occurrence of diseases such as flu, hepatitis, AIDS, and STDs. Over the period 2015-2025, the global medication market is expected to increase.
Due to parabolic incidences of microorganism epidemic breakouts and large investments in research and development, leading companies are projected to be important growth drivers for virology over the study period. In 2017, the global virology market was valued at $1693 million, and it is expected to increase at a CAGR of 5.4 per cent from 2018 to 2023.
According to the most recent data, Europe dominates the virology market, owing to the best infrastructure for dealing with complex application technologies, higher outlay, and the region's accessibility to top entrepreneurs. North America, after Europe, has the second largest virology market, while Asia has the third-largest market. Because of the rapid expansion of pharma infrastructure, Asia-Pacific is expected to grow the fastest.
Because of technical improvements such as speedy, portable diagnostics, North America is the largest medicine market junction rectifier by the United States. North America is likely to maintain its market leadership during the forecast period.
Japan has a thriving virology market that is expected to develop at a phenomenal CAGR until 2025.This study depicts the size of the virology market from 2016 to 2018 and forecasts until 2022.
This virology study focuses on the market drivers, growth indicators, restraints, and problems that the virology market faces, as well as several other critical variables.
Viral tests assist in identifying viruses that cause infections. Viruses can be identified using a variety of techniques, including hemagglutination assays, specific antibody detection, antigen detection, virus nucleic acid detection, and gene sequencing. Interferon, antiviral chemotherapy, and monoprophylaxis are all effective ways to manage viral infection. The market is segmented into Diagnostic Test: DNA Viruses, RNA Viruses, Prions Diagnostic Test, and Other Viral Tests based on the kind of product.
Hepatitis B, Hepatitis C, HIV, Human papillomavirus (HPV), and other tests (including influenza, Ebola, and dengue) are predicted to hold the greatest market shares globally over the projected period in terms of diagnosis tests. Monoprophylaxis, Active Prophylaxis (Vaccines), Passive Prophylaxis, Antiviral Chemotherapy (Veridical Agents, Antiviral Agents, Immunomodulators), and Interferon's are all methods for managing viral infections (Cytokines). The market segments with the greatest rate of growth during the anticipated forecast period are monoprophylaxis therapy and antiviral medications.
Skin and soft tissue infections, respiratory tract infections, GI tract infections, urinary tract infections, eye infections, sexually transmitted diseases, and perinatal infections are the different applications that make up the virology market. In the global market, STDs, urinary tract infections, and respiratory tract infections now have a disproportionate amount of market share. The market is segmented into Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, and Pharmacies based on the end users.
Hospitals and laboratories, which together account for almost half of the global market share, are expected to remain the most dominant end-use categories. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, the Middle East, and Africa make up the geographical segments of the virology market. Due to technology developments like portable diagnostics, the U.S. dominates the largest market in North America. Over the course of the forecast, North America is anticipated to maintain a strong market position.
According to Data Bridge Market Research, the Virology Testing Market, which had a value of USD 4,108.27 million in 2021, will soar to USD 7717.51 million by 2029 and have a CAGR of 8.20% from 2022 to 2029. The market report created by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework in addition to market insights like market value, growth rate, market segments, geographic coverage, market players, and market scenarioThe market for virology testing is anticipated to expand significantly. The most recent molecular-based virology testing techniques, such as immunoassay, mass spectrometry-based detection techniques, nucleic acid-based amplification testing techniques, and next-generation genome sequencing techniques, are accurate, efficient, and capable of detecting a variety of viral infections.
According to Data Bridge Market Research, the virology testing market, which had a value of USD 4,108.27 million in 2021, will soar to USD 7717.51 million by 2029 and see a CAGR of 8.20% from 2022 to 2029. The market report created by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework in addition to market insights like market value, growth rate, market segments, geographic coverage, market players, and market scenario.
Virology Testing Market Dynamics
- Rising number of patients with STDs
The market for virology testing is expected to expand during the forecast period of 2022–2029 due to factors like the rising number of patients with STDs, STD-related illnesses, and other viruses, as well as the availability of immune suppressive medications and the rising number of technological advancements in the healthcare sector. Though there will be various new opportunities for the virology testing market to grow during the forecast period as a result of the advancement of molecular diagnostic technologies.
Rising incidence of viral infections
Rising viral infection rates, the emergence of new diseases, and an increase in product approvals will be the key driving forces. For instance, the World Health Organization (WHO) predicts that 60% of the world's population would be afflicted by infectious diseases in 2021. The rising incidence of viral diseases such the human immunodeficiency virus (HIV), influenza, Ebola, Zika virus, and other sexually transmitted diseases has raised the demand for virology testing.
- Increased healthcare spending
The rapid advancements in diagnostic and testing methods, rising healthcare costs, benevolent government regulations, and the presence of state-of-the-art clinical laboratories and manufacturing companies have all aided in the market's steady expansion in the region over time. The increase in R&D efforts from public and private entities in the US is a significant factor in the market's growth.
- Stringent regulations regarding product development and approvals
On the other hand, the market's growth rate will be hampered by the strict approval procedures, adverse effects of the medications, and other treatment options. The market for virology testing will face difficulties due to a shortage of highly qualified workers and a lack of healthcare infrastructure in emerging nations.
This report on the global virology testing market details recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic data, and Contact Data Bridge Market Research for an Analyst brief to learn more about the virology testing market.
COVID-19 Impact on Virology Testing Market
The COVID-19 pandemic has had a substantial impact on the growth of the segment as well. The majority of diagnostic tests use RT-PCR to screen individuals with COVID-19 symptoms because the relevant viral culture tests have not been advised by the authorities. Most pharmaceutical and biotechnological companies are focusing on research and development activities to uncover new drugs or leads for the treatment of COVID-19.
- In May 2021, Cipla Limited launched "ViraGen" as a polymerase chain reaction (COVID-19 RT-PCR) test for COVID-19 in India in partnership with Ubio Biotechnology Systems Pvt. Ltd.
- A unique respiratory panel test called Q-POC SARS-CoV-2, Flu A/B & RSV Assay was released in May 2022, according to QuantuMDx Group Limited. Customers can get quick point-of-care testing with the Q-POC platform's multiplex capabilities in both clinical and non-clinical settings.
- A brand-new, incredibly sensitive SARS-CoV-2 Rapid Antigen Test -AQ+ Covid-19 Ag Rapid Test for professional use was released by InTec in January 2022. The AQ+ Covid-19 Ag Rapid Test is intended for use by laypersons or medical professionals to swiftly and simply detect Covid-19.
Global Virology Testing Market Scope
On the basis of technique, diagnosis test, method, application, and end user, the virology testing market is divided. You may analyse the industries' sparse growth segments with the help of these segments' expansion, and you can give users a useful market overview and industry insights to aid them in discovering key market applications.
- Cell Culture Method
- Specific Antibodies Detection
- Antigen Detection
- Virus Nucleic Acid Detection
- Gene Sequencing
- Hemagglutination Assays
- Hepatitis B
- Hepatitis C
- Human Papillomavirus (HPV)
- Other Tests
- Active Prophylaxis (Vaccines)
- Passive Prophylaxis
- Antiviral Chemotherapy
- Interferon's (Cytokines)
- Skin and Soft Tissue Infections
- Respiratory Tract Infections
- GI Tract Infections
- Urinary Tract Infection
- Eye Infections
- Sexually Transmitted Diseases
- Perinatal Infections
- Diagnostic Centres
- Blood Banks
Virology Testing Market Regional Analysis/Insights
The virology testing market is examined, and data on market size and trends are given for each nation, method, diagnosis test, application, and end user.
The United States, Canada, and Mexico make up North America, while Germany, France, the United Kingdom, the Netherlands, Switzerland, Belgium, Russia, Italy, Spain, and Turkey make up Europe. Other nations covered in the report include China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and the rest of Asia-Pacific (APAC), as well as Saudi Arabia, the United Arab Emirates, South Africa, Egypt, Israel, and the rest of the Middle East and Africa (MEA).
Due to advancements in portable diagnostic technology, North America currently controls the majority of the market for virology testing.
Due to its advanced infrastructure investment, Asia-Pacific is anticipated to grow at the greatest rate throughout the projected period of 2022 to 2029.
The nation part of the research also lists specific market-impacting variables and domestic market regulation changes that have an effect on the market's present and future tendencies. Data points like technical trends, porter's five forces analysis, case studies, and value chain analysis upstream and downstream are some of the indicators utilised to anticipate the market scenario for certain nations. When giving prediction analysis of the country data, it also takes into account the presence and accessibility of international brands as well as the difficulties they encounter due to strong or weak competition from local and domestic brands, the influence of domestic tariffs, and trade routes.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The virology testing market also gives you a thorough market analysis for every nation, including information on the installed base of various virology testing market products, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and how they affect the virology testing market.
Some of the major players operating in the virology testing market are:
- F. Hoffmann-La Roche Ltd (Switzerland)
- Agilent Technologies, Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- QIAGEN (Germany)
- Lonza (Switzerland)
- Sigma-Aldrich Co. (U.S.)
- Wuxi AppTec (China)
- Merck & Co. Inc. (U.S.)
- Eurofins Scientific (Luxembourg)
- General Electric (U.S.)
- Danaher (U.S.)
- Sartorius AG (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
- BD (U.S.)
- Biospherix, Ltd (U.S.)
- Novogene Co Ltd. (China)